PortfoliosLab logoPortfoliosLab logo

iShares U.S. Pharmaceuticals ETF (IHE) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with IHE. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to IHE

IHE charges 0.38% annually. There are 15 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.08%.


Best Risk-Adjusted Alternatives to IHE

IHE has a PortfoliosLab risk / return rank of 95. There is 1 ETF in the Health & Biotech Equities category with a higher risk-adjusted rank, going as high as 96.


Top Performing IHE Alternatives (YTD)

IHE is at 19.36% YTD. There are 12 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 36.76%.


Lowest Volatility Alternatives to IHE

IHE has 17.83% 1-year volatility. There are 23 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 0.00%.


Lowest Drawdown Alternatives to IHE

IHE has a 1-year max drawdown of -8.47%. There are 5 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as 0.00%.


Other ETFs from iShares

The 10 most viewed iShares ETFs shown here include SGOV, IBIT, SOXX and span 14 categories. AUM among these funds goes as high as $869B.


Often Compared With IHE

Investors most often compare IHE with PPH, VYM, IAK. These 20 comparison targets span 8 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
VanEck Pharmaceutical ETFHealth & Biotech Equities
74
6.76%
925.60MDec 2011IHE vs PPH
Vanguard High Dividend Yield ETFDividend
92
14.80%
96.20BNov 2006IHE vs VYM
iShares U.S. Insurance ETFFinancials Equities
54
10.11%
537.00MMay 2006IHE vs IAK
Virtus LifeSci Biotech Products ETFHealth & Biotech Equities
88
17.95%
101.39MDec 2014IHE vs BBP
Teva Pharmaceutical Industries Limited
97
10.41%
IHE vs TEVA
Direxion Daily Pharmaceutical & Medical Bull 3X Sh...Leveraged Equities
95
54.54%
22.43MNov 2017IHE vs PILL
Fidelity 500 Index FundS&P 500
59
10.13%
Feb 1988IHE vs FXAIX
SPDR S&P Biotech ETFHealth & Biotech Equities
93
20.93%
9.90BFeb 2006IHE vs XBI
Horizon Kinetics Medical ETFHealth & Biotech Equities
56
4.29%
17.80MSep 1999IHE vs MEDX
ProShares S&P 500 Dividend Aristocrats ETFDividend, S&P 500, Large Cap Value Equities
51
11.50%
11.68BOct 2013IHE vs NOBL
Jpmorgan Healthcare Leaders ETFHealth & Biotech Equities
63
4.29%
9.07MNov 2023IHE vs JDOC
Janus Henderson Global Life Sciences Fund Class THealth & Biotech Equities
92
8.07%
Dec 1998IHE vs JAGLX
iShares Nasdaq Biotechnology ETFHealth & Biotech Equities
84
10.25%
9.21BFeb 2001IHE vs IBB
Invesco S&P 500 Equal Weight Health Care ETFHealth & Biotech Equities, S&P 500, Equal Weight
67
10.63%
766.87MNov 2006IHE vs RSPH
Fidelity Select Pharmaceuticals PortfolioHealth & Biotech Equities
92
11.86%
Jun 2001IHE vs FPHAX
iShares Global Healthcare ETFHealth & Biotech Equities
56
3.49%
4.09BNov 2001IHE vs IXJ
T. Rowe Price Health Care ETFHealth & Biotech Equities, Actively Managed
87
14.31%
Jun 2025IHE vs TMED
Global X Aging Population ETFHealth & Biotech Equities
44
3.77%
87.24MMay 2016IHE vs AGNG
iShares Neuroscience and Healthcare ETFHealth & Biotech Equities
90
13.54%
5.49MAug 2022IHE vs IBRN
F/m Emerald Life Sciences Innovation ETFHealth & Biotech Equities
94
24.59%
74.65MOct 2024IHE vs LFSC

Compare IHE with Any Fund or Stock

Compare IHE with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair IHE with funds that move differently

iShares U.S. Pharmaceuticals ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to IHE.

Explore IHE Diversifiers